BridgeBio Pharma Awards Equity Shares to 11 New Employees
BridgeBio Pharma, Inc. (BBIO) has awarded equity shares to 11 new employees, totalling 23,884 shares of common stock. The grants were made under the company's Amended and Restated 2019 Inducement Equity Plan, with a vesting schedule commencing on November 16, 2026.
The equity grants are in the form of restricted stock units (RSUs). The BridgeBio Pharma compensation committee approved these grants on October 2, 2025. The company's governance and compensation committees carried out the Amendments and Restatements of the plan on February 10, 2023, and December 13, 2023, as part of updating the 2019 Inducement Equity Plan. No specific individual signatories are mentioned in the available sources.
BridgeBio Pharma has awarded equity shares to 11 new employees, with a total of 23,884 shares of common stock. The grants are part of the company's Amended and Restated 2019 Inducement Equity Plan, with a vesting schedule starting in late 2026. The compensation committee approved the grants in October 2025.
Read also:
- Unveiling the Less-Discussed Disadvantages of Buds - Revealing the Silent Story
- Grid Risk Evaluation Strategy By NERC Outlined, Focusing on Potential Threats from Data Centers
- Rapid Expansion in Organic Rice Protein Market Projected at 15.6% Through 2034
- Vantor & Lanteris Fuel US Intelligence with Innovative Tech
